Radioactive microspheres show promise in early liver cancer trial

NCT ID NCT06310590

Completed Disease control Sponsor: Chengdu New Radiomedicine Technology Co. LTD. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This completed Phase 1 trial tested a new injection called NRT6003, which contains tiny radioactive beads (yttrium-90), in 40 people with liver cancer that could not be removed by surgery. The goal was to see if the treatment is safe and whether it can shrink tumors in the liver. Researchers measured side effects and how long it took for the cancer to progress.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Yttrium-90 carbon microspheres (NRT6003 injection)
What this could lead to: If it works, this could offer a new radiation treatment option for people with liver cancer that cannot be surgically removed.
What could go wrong: This is a small, early-phase (Phase 1) trial with only 40 participants, so results may not apply broadly. The treatment involves radiation and could cause side effects like liver damage or other adverse events.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UNRESECTABLE HEPATOCELLULAR CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hepatocellular carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

UNRESECTABLE HEPATOCELLULAR CARCINOMA

Contacts and locations

Locations

Anhui Provincial Hospital

Hefei, Anhui, China
Henan Cancer Hospital

Zhengzhou, Henan, China
Hunan Provincial People's Hospital

Changsha, Hunan, China
The Affiliated Hospital of Southwest Medical University

Luzhou, Sichuan, China
The First Affiliated Hospital of Jinan University

Guangzhou, Guangdong, China
The First Affiliated Hospital of Wenzhou Medical University

Wenzhou, Zhejiang, China
West China Hospital, Sichuan University

Chengdu, Sichuan, China
Zhejiang Cancer Hospital

Hangzhou, Zhejiang, 310022, China
Zhongda Hospital, Southeast University

Nanjing, Jiangsu, 210009, China
Zhongshan Hospital, Fudan University

Shanghai, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.